Karyopharm Therapeutics, Inc. (KPTI)

9.30 +0.53 (+6.04%) USD  |  NASDAQ  |  May 04, 16:00
9.30 0.00 (0.00%) After-Hours: 18:56
More

Karyopharm Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for KPTI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Agios Pharmaceuticals, Inc. Upgrade